Coronavirus, stem cell “powder” against lung damage from Covid 19

0
10


The search to stem, fight, cure and one day prevent COVID-19 continues unabated. A “powder” obtained from mesenchymal stem it could counteract lung damage caused by coronavirus-triggered disease SARS-CoV-2. The technology to obtain it has been developed and patented byUniversity of Pavia and published in the magazine cells, and if clinical studies confirm its efficacy, already shown by laboratory tests, it will allow low cost production. The one contained in the powder is the ‘secretome’, a pool of substances produced by the mesenchymals consisting of a cocktail of proteins, lipids, genetic material and other molecules which, overall, they show anti-inflammatory, regenerative and anti-fibrotic effects in preclinical tests. “The secretoma we are studying is produced by mesenchymal stem cells, which are found in various tissues, including the medulla, fat, umbilical cord and even placenta – he explains Maria Luisa Torre, creator of the project and head of the Cell Delivery System Lab of the University of Pavia -. Italy is at the forefront of the clinical use of these cells in Covid 19, because they can have a therapeutic effect and a regenerative function on the respiratory system affected by Covid, precisely through the mix of substances they produce “.

If stem cells are already classified as a medicinal product, the secretoma is not yet a drug but, if it were confirmed as safe and effective as the stem cells from which it derives, it could become so thanks to the process of transformation into powder, the result of Italian research, which makes it usable for inhalation or injectable administration. THEthe advantage is that it could be produced on a large scale at affordable costs and it would be more readily available for a large number of patients, even in developing countries, where there are no suitable resources and facilities for cell therapy.

Two studies are already active in China on healthy volunteers or with Covid-19, to evaluate their safety, in the first case, and efficacy in the second; and also in Italy experiments have been launched on the animal which hopefully will soon arrive in the clinic. “Although research is still limited, the secretoma would seem effective and above all safe: no side effects have ever been observed, even at high dosages – continues Torre – pFor example, he has a low risk of inducing embolisms after administration, has not induced the appearance of tumors, and appears to be immune-privileged just like the stem cells from which it derives. In other words, a secretome obtained from a non-histocompatible subject can also be used without activating an immune response “.

“The secretoma can be produced in the laboratory and, even in the absence of cells, it could regulate the immune and inflammatory response, stimulate the tissues and reduce the pulmonary fibrosis that results from the infection – he says Elia Bari, researcher of the Department of Pharmaceutical Sciences of the University of Pavia, creator of the new technology and author of the study published on Cells -, With the all-Italian technology that we have developed, it is also possible to transform it into a freeze-dried powder and pack it in ampoules as a drug. The prototypes of injectable or inhalable solutions already exist – adds Elia Bari – but if the secretome became a drug it could be produced on a large scale at costs comparable to those of traditional biological drugs and would be more easily available for many patients even in developing countries where cell therapy cannot be used due to lack of resources and structures “.

Meanwhile StemNet, the Federation of stem cell research associations, has declared itself in favor of the clinical use of cell therapies against Covid 19. “The mechanisms of effectiveness are not fully clarified and we cannot say with certainty the validity of this therapeutic approach, which seems to be attributable to anti-inflammatory and tissue damage protection activities – he intervenes Augusto Pessina, President of StemNet and member of the StaMeTec Coordinated Research Center of the University of Milan – However, taking into account the considerable safety of mesenchymal stem / stromal cells and their products – he adds – secretoma and extracellular vesicles, it is desirable to evaluate their targeted clinical use in seriously compromised and life threatening patients, necessarily following the current regulations of the phase I / II clinical trial or within compassionate uses “.

The Cells Study

Coronavirus memorial

Support ilfattoquotidiano.it: never like now
we need you.

In these weeks of pandemic we journalists, if we do our job with conscience,
                        we do a public service. This is also why we are proud every day here at ilfattoquotidiano.it
                        to offer hundreds of new content for free to all citizens: news, exclusive insights,
                        expert interviews, surveys, videos and much more. All this work, however, has a great economic cost.
                        Advertising, in a time when the economy is stagnant, offers limited revenues.
                        Not in line with the access boom. This is why I ask those who read these lines to support us.
                        To give us a minimum contribution, equal to the price of a cappuccino per week,
                        fundamental for our work.
Become a supporting user by clicking here.

Thanks
Peter Gomez

But now we are the ones who need you.
                        Because our work has a cost.
                        We are proud to be able to offer hundreds of new content every day for free to all citizens.
                        But advertising, in a time when the economy is stagnant, offers limited revenues.
                        Not in line with the boom in access to ilfattoquotidiano.it.
                        This is why I ask you to support us, with a minimum contribution, equal to the price of a cappuccino per week.
                        A small but fundamental sum for our work. Help us out!
Become a supporting user!

With gratitude
Peter Gomez


ilFattoquotidiano.it

Support now


Available payments

Previous article

The Tasmanian sky “moves”: the spectacular video of the Milky Way in timelapse

next




Source link
https://www.ilfattoquotidiano.it/2020/05/27/coronavirus-polvere-di-cellule-staminali-contro-i-danni-ai-polmoni-da-covid-19/5815465/

LEAVE A REPLY

Please enter your comment!
Please enter your name here